4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-23-005554
Prin. Fin. and Acctg. Officer sold 1,697 shares at an average $5.08 ($8,621)
- Prin. Fin. and Acctg. Officer acquired 5,940 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Donegan Michael C · Prin. Fin. and Acctg. Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-26 | Exercise or conversion : show line 1 in the form | +2,400 | 10,010 | D | ||
| 2023-01-26 | Exercise or conversion : show line 2 in the form | +2,400 | 12,410 | D | ||
| 2023-01-26 | Exercise or conversion : show line 3 in the form | +1,140 | 13,550 | D | ||
| 2023-01-26 | Sale : show line 4 in the form | −1,648 | $5.08 | $8,371 | 11,902 | D |
| 2023-01-27 | Sale : show line 5 in the form | −49 | $5.09 | $249 | 11,853 | D |
| Open-market sales · 1,697 sh · avg $5.08 · $8,621 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-26 | Exercise or conversion : show line 6 in the form Performance Stock Units | −2,400 | 0 | D |
| 2023-01-26 | Exercise or conversion : show line 7 in the form Performance Stock Units | −2,400 | 0 | D |
| 2023-01-26 | Exercise or conversion : show line 8 in the form Performance Stock Units | −1,140 | 0 | D |
Loading xslF345X03/doc4.xml…